Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for GRFS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 150.05M
September 30, 2025 -3.902M
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
March 31, 2021 28.30M
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
Date Value
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 -0.0811M
September 30, 2016 7.371M
June 30, 2016 5.726M
March 31, 2016 0.00
December 31, 2015 0.2036M
September 30, 2015 -0.1247M
June 30, 2015 -14.16M
March 31, 2015 0.00
December 31, 2014 8.685M
September 30, 2014 22.37M
June 30, 2014 60.80M
March 31, 2014 0.00
December 31, 2013 -105.00M
September 30, 2013 0.2228M
June 30, 2013 -24.78M
March 31, 2013 109.96M
December 31, 2012 0.009M
September 30, 2012 0.00
June 30, 2012 0.0026M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
argenx SE --
Evaxion AS 0.00
Autolus Therapeutics Plc -0.003M
Pharma Mar SA -2.319M
Oryzon Genomics SA 0.00